Bionomics Statistics
Total Valuation
Bionomics has a market cap or net worth of $5.29 million. The enterprise value is -$2.60 million.
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Bionomics has 19.53 million shares outstanding. The number of shares has increased by 41.23% in one year.
Current Share Class | n/a |
Shares Outstanding | 19.53M |
Shares Change (YoY) | +41.23% |
Shares Change (QoQ) | +48.77% |
Owned by Insiders (%) | 0.19% |
Owned by Institutions (%) | 7.31% |
Float | 16.73M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.25 |
P/TBV Ratio | 1.84 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.30, with a Debt / Equity ratio of 0.01.
Current Ratio | 3.30 |
Quick Ratio | 3.21 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -55.39% and return on invested capital (ROIC) is -50.11%.
Return on Equity (ROE) | -55.39% |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | -50.11% |
Revenue Per Employee | n/a |
Profits Per Employee | -$451,016 |
Employee Count | 24 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -184,714 |
Effective Tax Rate | n/a |
Dividends & Yields
Bionomics does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -41.23% |
Shareholder Yield | -41.23% |
Earnings Yield | -205.61% |
FCF Yield | -278.92% |
Analyst Forecast
The average price target for Bionomics is $8.00, which is 2,852.03% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $8.00 |
Price Target Difference | 2,852.03% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |